| D007700 |
Kinetics |
The rate dynamics in chemical or physical systems. |
|
|
| D011355 |
Prodrugs |
A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. |
Drug Precursor,Drug Precursors,Pro-Drug,Prodrug,Pro-Drugs,Precursor, Drug,Precursors, Drug,Pro Drug,Pro Drugs |
|
| D006207 |
Half-Life |
The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. |
Halflife,Half Life,Half-Lifes,Halflifes |
|
| D006868 |
Hydrolysis |
The process of cleaving a chemical compound by the addition of a molecule of water. |
|
|
| D013936 |
Thymidine |
A nucleoside in which THYMINE is linked to DEOXYRIBOSE. |
2'-Deoxythymidine,Deoxythymidine,2' Deoxythymidine |
|
| D013942 |
Thymine Nucleotides |
Phosphate esters of THYMIDINE in N-glycosidic linkage with ribose or deoxyribose, as occurs in nucleic acids. (From Dorland, 28th ed, p1154) |
Thymidine Phosphates,Nucleotides, Thymine,Phosphates, Thymidine |
|
| D054306 |
Dideoxynucleotides |
The phosphate esters of DIDEOXYNUCLEOSIDES. |
Dideoxynucleotide Triphosphates,ddNTPs,Triphosphates, Dideoxynucleotide |
|
| D018119 |
Stavudine |
A dideoxynucleoside analog that inhibits reverse transcriptase and has in vitro activity against HIV. |
2',3'-Didehydro-3'-deoxythymidine,D4T,2',3'-Didehydro-2',3'-dideoxythmidine,BMY-27857,Stavudine, Monosodium Salt,Zerit,2',3' Didehydro 3' deoxythymidine,BMY 27857,BMY27857 |
|